Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine, Cisplatin, and 5-Fluorouracil in Advanced Pancreatic Cancer
NCT00004003Phase 2Completed
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- Apr 1999
- Primary completion
- Nov 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of gemcitabine, cisplatin and fluorouracil in pancreatic cancer (PC), gallbladder cancer and biliary tract cancer (BTC), sponsored by Barbara Ann Karmanos Cancer Institute. Primary endpoint: Overall Survival. Started Apr 1999; status: completed.
02
Drugs
gemcitabinecisplatinfluorouracil
03
Conditions
pancreatic cancer (PC)gallbladder cancerbiliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT00004003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004003.